{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-22-011646","form_type":"8-K","ticker":"JANX","cik":"0001817713","company_name":"Janux Therapeutics, Inc.","filed_at":"2022-06-15T23:59:59+00:00","discovered_at":"2026-05-14T18:04:02.464929+00:00","generated_at":"2026-06-25T01:41:13.568084+00:00","sec_items":["5.07"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"Janux Therapeutics stockholders elect three Class I directors, ratify auditor at 2022 annual meeting","bullets":["David Campbell, Ron Barrett, and Stefan Heller elected as Class I directors with 33.9M, 34.7M, and 33.9M votes for, respectively.","Ernst & Young LLP ratified as independent auditor for FY2022 with 37.85M votes for, 3 against, 244 abstentions.","Broker non-votes of 2,998,529 on all director elections; none on auditor ratification.","Total outstanding shares as of record date April 18, 2022: 41,629,367."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-22-011646","json":"https://secwatch.observer/filing/0000950170-22-011646.json","markdown":"https://secwatch.observer/filing/0000950170-22-011646.md","text":"https://secwatch.observer/filing/0000950170-22-011646.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1817713/000095017022011646/0000950170-22-011646-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1817713/000095017022011646/janx-20220614.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-25T01:41:13.568084+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}